# SMARCAD1

## Overview
SMARCAD1 is a gene that encodes the SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1 protein, which is a member of the chromatin remodeler family. This protein is characterized by its SNF2-like ATPase domain and DEAD/H box helicase domain, which are essential for its role in ATP-dependent chromatin remodeling and DNA repair processes (Ding2018The; Lo2021SMARCAD1mediated). SMARCAD1 is involved in maintaining genome integrity by stabilizing replication forks and preventing replication stress, thereby playing a critical role in DNA replication and repair (Lo2021SMARCAD1mediated). The protein interacts with various partners, including KRAB-associated protein 1 (KAP1) and components of the TFIIIC complex, to facilitate chromatin organization and gene regulation (Ding2018The; Sachs2023The). Clinically, mutations in SMARCAD1 are associated with Basan syndrome and have implications in cancer, where its expression levels can influence chemotherapy response and serve as a potential biomarker for treatment outcomes (Lo2021SMARCAD1mediated; Wahl2019The).

## Structure
SMARCAD1 is a chromatin remodeler characterized by a conserved SNF2-like ATPase domain, which is a hallmark of ATP-dependent chromatin remodeling enzymes (Ding2018The). The protein is approximately 1,000 amino acids in size and functions in a homodimeric form in yeast, though in humans, it may operate as part of a complex rather than independently (Tong2020The). SMARCAD1 contains tandem ubiquitin-binding CUE domains near the N-terminus, which are involved in protein interactions, particularly with KRAB-associated protein 1 (KAP1) (Ding2018The; Biasutto20191H). The CUE1 domain is crucial for binding to KAP1, while the CUE2 domain is not required for this interaction (Ding2018The).

The protein also features a DEAD/H box helicase domain, essential for its ATPase activity, which is involved in chromatin remodeling and DNA repair processes (Lo2021SMARCAD1mediated). SMARCAD1 undergoes post-translational modifications, such as phosphorylation by ATM kinase at T906, which is important for its role in DNA damage response (Tong2020The). The protein's structure and function are further diversified by alternative splicing, resulting in multiple isoforms (Lo2021SMARCAD1mediated).

## Function
SMARCAD1 is a chromatin remodeler that plays a crucial role in maintaining genome integrity by stabilizing replication forks in healthy human cells. It is part of the SWI/SNF family of chromatin remodelers and is involved in various cellular processes, including DNA replication and repair. SMARCAD1 interacts with PCNA, a protein associated with the replication machinery, to ensure proper replication fork progression and stability, which is essential for genome integrity (Lo2021SMARCAD1mediated).

SMARCAD1 is localized to replication forks through its interaction with PCNA, and this localization is vital for its function in replication fork dynamics. It prevents the accumulation of 53BP1-associated nucleosomes at replication forks, which can lead to fork stalling and inefficient restart. This activity is crucial for cellular tolerance to replication stress-inducing agents (Lo2021SMARCAD1mediated).

In the absence of SMARCAD1, cells exhibit increased single-stranded DNA and activation of the ATR-mediated checkpoint pathway, indicating replication stress. This stress results in frequent fork stalling and the formation of reversed forks, even under unperturbed conditions (Lo2021SMARCAD1mediated). SMARCAD1's role in maintaining PCNA levels at replication forks is essential for efficient DNA synthesis and fork progression, ensuring genome stability (Lo2021SMARCAD1mediated).

## Clinical Significance
Mutations and altered expression of the SMARCAD1 gene have significant clinical implications. SMARCAD1 mutations are linked to Basan syndrome, a subtype of ectodermal dysplasia characterized by adermatoglyphia, facial milia, acral blisters, and nail abnormalities. This condition results from a heterozygous mutation affecting a conserved donor splice site, leading to haploinsufficiency and abnormal expression of genes related to epidermal growth factor receptor regulation and keratinocyte proliferation (Wahl2019The).

In cancer, SMARCAD1 plays a crucial role in maintaining genome stability. Alterations in its expression are associated with various cancers, including colorectal, testicular germ cell, and head and neck squamous cell carcinomas, suggesting a potential tumor-suppressor role (Ferraro2016Altered). In BRCA1-deficient tumors, low SMARCAD1 expression correlates with longer progression-free survival in patients treated with platinum-based chemotherapy, while high expression is linked to poor chemotherapy response. This indicates that SMARCAD1 could serve as a biomarker for chemotherapy resistance and a target for therapeutic intervention in BRCA1-deficient cancers (Lo2021SMARCAD1mediated). These findings underscore the importance of SMARCAD1 in cancer progression and treatment outcomes.

## Interactions
SMARCAD1 interacts with several proteins, playing a crucial role in chromatin remodeling and gene regulation. A significant interaction is with KRAB-associated protein 1 (KAP1), where SMARCAD1 binds directly via its CUE1 domain to the RBCC domain of KAP1. This interaction is essential for the nuclear retention of SMARCAD1 and its binding to KAP1 target genes, which include zinc finger protein and imprinted genes (Ding2018The). Mutations in the CUE1 domain, such as F169K and L196K, disrupt this interaction, leading to reduced nuclear retention and decreased binding to KAP1 target genes (Ding2018The).

SMARCAD1 also associates with components of the TFIIIC complex, including TFIIIC63 and TFIIIC90, and architectural proteins like cohesin subunits SMC1A and SMC3, and the RNA helicase DDX5. These interactions are mediated by protein-protein interactions rather than nucleic acids (Sachs2023The). SMARCAD1's interaction with TFIIIC is direct and conserved across different cell types, including mouse embryonic stem cells and human somatic cells (Sachs2023The). These interactions suggest SMARCAD1's involvement in chromatin organization and genome stability.


## References


[1. (Ding2018The) Dong Ding, Philipp Bergmaier, Parysatis Sachs, Marius Klangwart, Tamina Rückert, Nora Bartels, Jeroen Demmers, Mike Dekker, Raymond A. Poot, and Jacqueline E. Mermoud. The cue1 domain of the snf2-like chromatin remodeler smarcad1 mediates its association with krab-associated protein 1 (kap1) and kap1 target genes. Journal of Biological Chemistry, 293(8):2711–2724, February 2018. URL: http://dx.doi.org/10.1074/jbc.ra117.000959, doi:10.1074/jbc.ra117.000959. This article has 32 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra117.000959)

[2. (Tong2020The) Ze-Bin Tong, Hua-Song Ai, and Jia-Bin Li. The mechanism of chromatin remodeler smarcad1/fun30 in response to dna damage. Frontiers in Cell and Developmental Biology, September 2020. URL: http://dx.doi.org/10.3389/fcell.2020.560098, doi:10.3389/fcell.2020.560098. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2020.560098)

[3. (Sachs2023The) Parysatis Sachs, Philipp Bergmaier, Katrin Treutwein, and Jacqueline E. Mermoud. The conserved chromatin remodeler smarcad1 interacts with tfiiic and architectural proteins in human and mouse. Genes, 14(9):1793, September 2023. URL: http://dx.doi.org/10.3390/genes14091793, doi:10.3390/genes14091793. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes14091793)

[4. (Wahl2019The) Lauren Wahl, Graham Dupont, and R. Shane Tubbs. The simian crease: relationship to various genetic disorders. Clinical Anatomy, 32(8):1042–1047, July 2019. URL: http://dx.doi.org/10.1002/ca.23432, doi:10.1002/ca.23432. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/ca.23432)

[5. (Biasutto20191H) Antonio J. Biasutto, Philip M. West, Erika J. Mancini, and Christina Redfield. 1h, 13c and 15n resonance assignments for the tandem cue domains from chromatin remodeler smarcad1. Biomolecular NMR Assignments, 13(2):261–265, March 2019. URL: http://dx.doi.org/10.1007/s12104-019-09888-9, doi:10.1007/s12104-019-09888-9. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12104-019-09888-9)

[6. (Ferraro2016Altered) Angelo Ferraro. Altered primary chromatin structures and their implications in cancer development. Cellular Oncology, 39(3):195–210, March 2016. URL: http://dx.doi.org/10.1007/s13402-016-0276-6, doi:10.1007/s13402-016-0276-6. This article has 36 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s13402-016-0276-6)

[7. (Lo2021SMARCAD1mediated) Calvin Shun Yu Lo, Marvin van Toorn, Vincent Gaggioli, Mariana Paes Dias, Yifan Zhu, Eleni Maria Manolika, Wei Zhao, Marit van der Does, Chirantani Mukherjee, João G. S. C. Souto Gonçalves, Martin E. van Royen, Pim J. French, Jeroen Demmers, Ihor Smal, Hannes Lans, David Wheeler, Jos Jonkers, Arnab Ray Chaudhuri, Jurgen A. Marteijn, and Nitika Taneja. Smarcad1-mediated active replication fork stability maintains genome integrity. Science Advances, May 2021. URL: http://dx.doi.org/10.1126/sciadv.abe7804, doi:10.1126/sciadv.abe7804. This article has 18 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/sciadv.abe7804)